Navigation Links
Joint Commission Alert: Effective Leadership Critical to Preventing Medical Errors
Date:8/27/2009

Leaders must take responsibility for patient safety

OAKBROOK TERRACE, Ill., Aug. 27 /PRNewswire-USNewswire/ -- A new Joint Commission Sentinel Event Alert issued today urges health care leaders to step up efforts to prevent errors by taking the zero-defect approach used in other high-risk industries such as aviation and nuclear energy. The Joint Commission is advocating greater involvement of health care trustees, executives, and physician leaders, contending that the overall safety and effectiveness of a health care facility depends on administrative and clinical leaders who set the tone, create the culture and drive improvements. In safe organizations, safety is rooted in the culture and the system, rather than in the behavior of individuals.

"Health care leaders are directly responsible for establishing a culture of safety," says Mark R. Chassin, M.D., M.P.P., M.P.H., president, The Joint Commission. "This Alert provides leaders with concrete strategies for demonstrating a commitment to safety and to improving patient outcomes."

To improve patient safety, The Joint Commission's Sentinel Event Alert recommends that the governing body, chief executive officer, senior managers and medical staff leaders at health care organizations take a series of 14 specific steps, including the following:

  • Define and establish an organization-wide safety culture that includes a code of conduct for all employees.
  • Institute an organization-wide policy of transparency that sheds light on all adverse events and patient safety issues.
  • Make the organization's overall safety performance a key, measurable part of the evaluation of the CEO and all leadership.
  • Ensure that caregivers involved in adverse events that result in unintentional patient harm receive attention that is just, respectful, compassion
    '/>"/>

SOURCE The Joint Commission
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
2. Joint NJ/NY Rally for Addiction Recovery to Be Hub of Events Nationwide
3. Joint Juice Launches New Ready-to-Drink Glucosamine & Vitamin-Enhanced Dietary Supplement Water Nationwide
4. SAIC Selected to Support the U.S. Military Theater Medical Information Program-Joint
5. The impact of physical activity on weight-bearing knee joint
6. Joint Center Says New Approach Required to Reduce Black Infant Mortality
7. Merlyn Medical Announces FDA Approval for FlexWarmer in a Joint Agreement with Elltec and Suzuken
8. The Joint Commission Enhances Quality Check Website
9. OCS and Press Ganey Partner to Create Joint Analysis of Outcomes and Satisfaction
10. More Damage Than Good? Shock Survey Reveals Sport can Actually be bad for Your Joints
11. Delaware Court Approves Bioenvision, Genzyme Joint Petition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... important human pathogen that can cause rapidly progressing, life ... said., "Until now we have not known how it ... long-standing mystery how it attaches to the airway to ... not get any symptoms, while some people progress to ... know the detail of how the bacterium colonises the ...
(Date:5/23/2013)... WEDNESDAY, May 22 (HealthDay News) -- The success of an ... with a serious airway malformation sheds light on new technology ... report in the May 23 New England Journal of ... At first, the baby born five weeks early seemed perfectly ... when he was 6 weeks old. Just two weeks later, ...
(Date:5/23/2013)... DRE, Inc. is now offering the ... solution to upgrade older model DRE or BFW halogen ... system. , DRE and BFW customers can easily ... halogen headlights to LED with DRE’s American-made Xavier-C3 LED ... Kit provides a bright, clean and even field of ...
(Date:5/23/2013)... 2013 In Florida, residents have not been ... mean, however, that Florida’s good luck will continue, warns Rick ... year, he encourages residents, it is important to prepare as ... are predicting there to be a 50-percent chance that a ... hurricane season lasting from June 1 to November 30 in ...
(Date:5/23/2013)... Natchitoches, LA (PRWEB) May 23, 2013 The ... website, has showed that Louisiana still tops the rest of ... annual average of $2,699 is more than double of that ... factors determine auto insurance rates, and those factors vary from ... that may be causing these high rates. , Compared ...
Breaking Medicine News(10 mins):Health News:New discovery in fight against deadly meningococcal disease 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 3Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 2Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 3Health News:As Hurricane Season Nears, Skylake Insurance Encourages Florida Residents To Prepare Early For Safety 2Health News:Cunningham Financial Group Wants Motorists to Understand Their Rates as Louisiana’s Auto Insurance Rates Remain the Highest in the Nation 2
... ... patients at risk for stroke. , ... (Vocus) May 26, 2010 -- After nine years of investigation, the ... Buffalo Neurosurgery , shows that two different procedures designed to prevent future strokes are ...
... , ... the first annual awards program saluting individual health care professionals who inspire, motivate and empower ... sector of the healthcare industry. The Dorland Health People Awards is calling for entries now, ... ...
... report that a recently introduced surgical procedure offers infants ... during their first year of life, in comparison to ... centers in the federally sponsored Pediatric Heart Network studied ... series of surgeries for hypoplastic left heart syndrome (HLHS). ...
... neck artery, study shows , WEDNESDAY, May 26 (HealthDay News) ... invasive stenting to help prevent stroke shows that each is ... 26 online edition of the New England Journal of ... patients treated at 117 centers across North America between 2000 ...
... Institute at University Hospitals has been designated as a ... Center of Excellence Survey sponsored by NeuStrategy, Inc., Chicago. ... to receive the Stage 4 Institute designation. ... its kind in the neurosciences and is the industry ...
... when compared to chemoradiotherapy alone , WEDNESDAY, May 26 ... failed to improve survival in patients with advanced lung ... in the final stage of testing, showed that the ... with inoperable stage III non-small cell lung cancer. , ...
Cached Medicine News:Health News:Landmark Clinical Trial Shows Surgery and Stenting Equally Safe and Effective at Preventing Stroke 2Health News:Landmark Clinical Trial Shows Surgery and Stenting Equally Safe and Effective at Preventing Stroke 3Health News:Landmark Clinical Trial Shows Surgery and Stenting Equally Safe and Effective at Preventing Stroke 4Health News:Landmark Clinical Trial Shows Surgery and Stenting Equally Safe and Effective at Preventing Stroke 5Health News:Dorland Health Announces People Awards Honoring Excellence & Dedication Among Healthcare Professionals - Call For Entries 2Health News:In infant heart surgery, newer technique yields better survival in first year of life 2Health News:In infant heart surgery, newer technique yields better survival in first year of life 3Health News:Surgery, Stenting Fare Equally Well in Preventing Stroke 2Health News:Surgery, Stenting Fare Equally Well in Preventing Stroke 3Health News:University Hospitals Neurological Institute earns Neuroscience Center of Excellence designation 2Health News:Shark Cartilage Not Beneficial in Advanced Lung Cancer 2
(Date:5/23/2013)... -- Omeros Corporation (NASDAQ: OMER ) today ... to evaluate OMS824 in Huntington,s disease has been ... (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), an ... to a wide range of diseases that affect ... shown promising results in animal models directly relevant ...
(Date:5/23/2013)... , May 23, 2013  Inhibikase Therapeutics, ... announced today that it will present new results ... an industry conference sponsored by the PML Consortium ... Idec).  JC polyomavirus (JCV) is the causative agent ... tyrosine kinase inhibitor in an extended release formulation, ...
(Date:5/23/2013)... 2013 InspireMD, Inc. ("InspireMD" ... in embolic protection stents, today announced new 6-month ... Elevation Reperfusion) trial demonstrating that the MGuard Embolic ... eluting stents in all-cause mortality in ST segment ... trial were presented at the InspireMD STEMI Symposium ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5
... Jan. 4, 2012  OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) ... custirsen (OGX-011/TV-1011) in patients with advanced non-small cell ... online version of the January 2012 issue of ... data provide additional clinical evidence for the potential ...
... announced today the closing of a $30 million Series B ... fund development of Elevation,s new aerosol therapy for patients living ... in the round, including Canaan Partners , TPG ... Venture Partners . In conjunction with this financing, Elevation has ...
Cached Medicine Technology:OncoGenex Announces Publication of Phase I/II Custirsen (OGX-011/TV-1011) Data in Journal of Thoracic Oncology 2OncoGenex Announces Publication of Phase I/II Custirsen (OGX-011/TV-1011) Data in Journal of Thoracic Oncology 3OncoGenex Announces Publication of Phase I/II Custirsen (OGX-011/TV-1011) Data in Journal of Thoracic Oncology 4Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy 2Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy 3
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Ultra Thin Sheet. Medpor Sheets are commonly used for orbital floor reconstruction and other craniofacial applications....
... Designed for precise punching of the ... designed for use with disposable trephine ... aids in centration of the donor ... block is held centrally under the ...
Broad Tip and Ultra-Micro Needle Tip, sterile, 10 per Box, 10 Boxes per Case...
Medicine Products: